| Title |
Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects
|
|---|---|
| Published in |
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, January 2012
|
| DOI | 10.2147/dmso.s27665 |
| Pubmed ID | |
| Authors |
Joe A Vinson, Bryan R Burnham, Mysore V Nagendran |
| Abstract |
Adult weight gain and obesity have become worldwide problems. Issues of cost and potential side effects of prescription weight loss drugs have led overweight and obese adults to try nutraceuticals that may aid weight loss. One promising nutraceutical is green coffee extract, which contains high concentrations of chlorogenic acids that are known to have health benefits and to influence glucose and fat metabolism. A 22-week crossover study was conducted to examine the efficacy and safety of a commercial green coffee extract product GCA™ at reducing weight and body mass in 16 overweight adults. |
X Demographics
The data shown below were collected from the profiles of 175 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 29 | 17% |
| Japan | 11 | 6% |
| Canada | 8 | 5% |
| Saudi Arabia | 8 | 5% |
| United Kingdom | 7 | 4% |
| Spain | 3 | 2% |
| Kuwait | 3 | 2% |
| Egypt | 2 | 1% |
| France | 2 | 1% |
| Other | 12 | 7% |
| Unknown | 90 | 51% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 154 | 88% |
| Practitioners (doctors, other healthcare professionals) | 19 | 11% |
| Scientists | 2 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 183 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 2% |
| Brazil | 1 | <1% |
| Switzerland | 1 | <1% |
| Spain | 1 | <1% |
| New Zealand | 1 | <1% |
| Unknown | 176 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 36 | 20% |
| Student > Bachelor | 23 | 13% |
| Student > Ph. D. Student | 22 | 12% |
| Student > Master | 22 | 12% |
| Other | 16 | 9% |
| Other | 42 | 23% |
| Unknown | 22 | 12% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 55 | 30% |
| Medicine and Dentistry | 46 | 25% |
| Nursing and Health Professions | 8 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 4% |
| Chemistry | 8 | 4% |
| Other | 23 | 13% |
| Unknown | 35 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 418. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2024.
All research outputs
#71,110
of 25,800,372 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#3
of 1,197 outputs
Outputs of similar age
#253
of 252,047 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#1
of 7 outputs
Altmetric has tracked 25,800,372 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,197 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 252,047 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them